Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 15 January 2024 31 January 2025 31 January 2025 15412129 Dr Marwan Al-Dawoud iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15412129 2024-01-14 15412129 2025-01-31 15412129 2024-01-15 2025-01-31 15412129 frs-core:CurrentFinancialInstruments 2025-01-31 15412129 frs-bus:PrivateLimitedCompanyLtd 2024-01-15 2025-01-31 15412129 frs-bus:FilletedAccounts 2024-01-15 2025-01-31 15412129 frs-bus:Micro-entities 2024-01-15 2025-01-31 15412129 frs-bus:AuditExempt-NoAccountantsReport 2024-01-15 2025-01-31 15412129 frs-bus:Director1 2024-01-15 2025-01-31
Registered number: 15412129
Md Med Limited
Unaudited Financial Statements
For the Period 15 January 2024 to 31 January 2025
Synergy Accountancy Services LLP
Chartered Certified Accountants
378 Walsall Road
Perry Barr
Birmingham
B42 2LX
Balance Sheet
Registered number: 15412129
31 January 2025
£
Fixed assets 2,611
Current assets 9,619
Creditors: Amounts Falling Due Within One Year (4,665 )
NET CURRENT ASSETS 4,954
TOTAL ASSETS LESS CURRENT LIABILITIES 7,565
Accruals and deferred income (1,320 )
NET ASSETS 6,245
CAPITAL AND RESERVES 6,245

Notes

1. General Information
Md Med Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15412129 . The registered office is 378 Walsall Road, Perry Barr, Birmingham, West Midlands, B42 2LX.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
Page 0
Page 1
For the period ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Marwan Al-Dawoud
Director
1 October 2025